M84.559 Pathological fracture in neoplastic disease, hip, unspecified

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Hip, Unspecified (ICD-10-CM: M84.559)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the hip. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the integrity of the hip, which may involve primary bone tumors or metastatic spread to this skeletal region.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the hip, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode hip bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the hip.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to hip sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often severe and unrelieved by rest.
• Swelling, bruising, or deformity around the hip.
• Inability to bear weight or move the affected leg.
• Limited range of motion in the hip joint.
• Possible signs of systemic malignancy, such as fatigue or weight loss.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A thorough history of cancer and symptoms is essential. Imaging studies, such as X-rays, CT scans, or MRI, confirm the fracture and assess bone integrity. Biopsies or tumor markers may identify the underlying neoplastic cause. Differential diagnosis excludes traumatic fractures or other bone disorders.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options include surgical fixation (e.g., pins, plates) to restore hip function, radiation therapy to target tumor-related bone damage, and systemic cancer treatments (e.g., chemotherapy, targeted therapy). Pain management and rehabilitation are critical for recovery.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the fracture's severity. Early intervention improves outcomes, but complications like infection or nonunion may occur. Regular follow-up with oncology and orthopedic teams monitors healing, cancer progression, and functional recovery.

Complications

• Delayed or nonunion of the fracture.
• Infection at the surgical site (if surgery is performed).
• Nerve damage or vascular injury.
• Progression of the underlying malignancy.
• Reduced mobility or long-term disability.

Lifestyle & Prevention

• Maintain bone health through adequate nutrition (calcium, vitamin D) and weight-bearing exercise, if appropriate.
• Follow cancer treatment plans to minimize bone weakening.
• Use assistive devices (e.g., walkers) to reduce fall risk.
• Avoid high-impact activities that could exacerbate bone fragility.

When to Seek Professional Help

Seek immediate medical attention for sudden, severe hip pain, inability to move the leg, or signs of fracture (e.g., deformity, swelling). Prompt evaluation is critical to prevent further damage and address underlying cancer.

Tips for Medical Coders

Document the fracture's relationship to neoplastic disease clearly, including the hip's involvement and any contributing factors (e.g., metastasis, treatment effects). Ensure the code M84.559 is used when the hip site is unspecified. Verify that the fracture is pathological (not traumatic) and linked to the neoplastic condition to support accurate coding.